Featured Slider

David Vodušek (DV): The AFAN, like the EAN, addresses and covers the neurological interest of a continent. Can you explain to the readers of the EANpages how was the AFAN created and why? Mansour Ndiaye (MN): Delegates from over 30 countries in Africa representing the interests of their national neurologic societies and associations met in Dakar, Senegal, over the weekend of August 29-30, 2015.

Albania, officially the Republic of Albania (in Albanian: Republika e Shqipërisë), is situated in South-East Europe on the West of Balkan peninsula. It is bordered with Montenegro to the northwest, Kosovo to the northeast, Republic of Macedonia to the east and Greece to the south and southeast. Albania has a long coastal line facing the Adriatic Sea on the west and the Ionian Sea on the south and southwest.

David Vodušek (DV):  The Lundbeckfonden Brain Prize is a very prestigious award. Can you illustrate to the EANpages readers how this prize came into existence and what is the scope of such a prize? Kim Krogsgaard (KK): In 2008 Lundbeckfonden’s board of trustees envisioned a large personal research prize within brain research.

For August 2016 we have selected: Gormley P, Anttila V, Winsvold BS, et al. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nature Genetics 2016 June 20;doi: 10.1038/ng.3598. Migraine is a worldwide common, disabling, and costly disease. Its pathophysiology has been related to either a primary vascular dysfunction or a primary neuronal dysfunction with secondary vascular involvement.

The International Parkinson Disease and Movement Disorders Society (MDS) Task Force on Genetic Nomenclature in Movement Disorders developed an online database providing a comprehensive overview of movement disorders phenotypes linked to causative gene mutations. MDSGene was just revealed at the… Continue Reading

  By Elena Moro   Video interview with Prof. A. Schapira editor-in-chief of the European Journal of Neurology was last modified: August 1st, 2016 by Editor… Continue Reading

We are delighted to announce that ebrain has now been approved by the Royal College of Physicians (UK) for CPD/CME up to a maximum of 9 external points per annum.

We congratulate the winners of the Investigator Awards to their presentation during the 2nd EAN Congress in Copenhagen 2016! The Prize consists of an Award certificate and free registration to the Amsterdam Congress. For the first time all winners’ presentations… Continue Reading

or April 2016 we have selected: Lublin F, Miller DH, Freedman MS, et al., on behalf of the INFORMS study investigators. Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomized, double-blind, placebo-controlled trial. Lancet Neurol, 27 Jan 2016; pii: S0140-6736(15)01314-8. doi: 10.1016/S0140-6736(15)01314-8. Primary progressive multiple sclerosis (PPMS) represents around 10-15% of the clinical forms of MS. Several characteristics differentiate PPMS from the relapse-onset MS, the classical more frequent form: older age at onset, equal prevalence between sexes, less inflammatory component at the MRI, and quicker progression of disability.

As in the previous years, EAN-RRFS delegate will join the EAN Spring School 2016 and the Regional Teaching courses (RTC) in order to spread information regarding postgraduate education in neurology and relevant opportunities for neurologists in training. This year, our representatives providing the updated information will be Panagiotis Zis (EAN Spring School 2016, May 12-15, 2016 Stare Splavy, Czech Republic), Orsolya Gyorfi (RTC, Kutasi, Georgia, Oct. 6-8, 2016), and Viktoria Papp (RTC, Yekaterinburg, Russia, Nov. 3-5, 2016).